Rxsight Free Cash Flow Per Share vs Free Cash Flow Yield Analysis

RXST Stock

USD 34.22 0.83 2.37%

Rxsight financial indicator trend analysis is much more than just breaking down Rxsight prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Rxsight is a good investment. Please check the relationship between Rxsight Free Cash Flow Per Share and its Free Cash Flow Yield accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rxsight. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.

Free Cash Flow Per Share vs Free Cash Flow Yield

Free Cash Flow Per Share vs Free Cash Flow Yield Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Rxsight Free Cash Flow Per Share account and Free Cash Flow Yield. At this time, the significance of the direction appears to have very strong relationship.

The correlation between Rxsight's Free Cash Flow Per Share and Free Cash Flow Yield is 0.87. Overlapping area represents the amount of variation of Free Cash Flow Per Share that can explain the historical movement of Free Cash Flow Yield in the same time period over historical financial statements of Rxsight, assuming nothing else is changed. The correlation between historical values of Rxsight's Free Cash Flow Per Share and Free Cash Flow Yield is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Per Share of Rxsight are associated (or correlated) with its Free Cash Flow Yield. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow Yield has no effect on the direction of Free Cash Flow Per Share i.e., Rxsight's Free Cash Flow Per Share and Free Cash Flow Yield go up and down completely randomly.

Correlation Coefficient

0.87

Relationship Direction	Positive
Relationship Strength	Strong

View All Relationships

Free Cash Flow Per Share

The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Most indicators from Rxsight's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Rxsight current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Rxsight. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Rxsight Stock please use our How to Invest in Rxsight guide.Enterprise Value is likely to gain to about 1.5 B in 2024, whereas Tax Provision is likely to drop slightly above 18.9 K in 2024.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	4.0M	4.0M	4.2M	4.4M
Interest Income	54K	1.5M	6.6M	6.9M

Depreciation And Amortization Interest Income

Rxsight fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Capital Lease Obligations	Inventory	Other Current Assets	Other Stockholder Equity
Total Assets		0.43	0.62	0.75	0.96	-0.79	0.96	-0.89	0.76	0.31	-0.81	0.46	0.72	-0.89	0.33	0.6	0.98	0.77	-0.95	0.62	0.98	-0.95	-0.78	0.71	0.89	0.95
Short Long Term Debt Total	0.43		0.25	0.31	0.45	-0.57	0.5	-0.37	0.19	0.98	-0.19	-0.36	0.73	-0.35	0.56	0.0	0.47	0.09	-0.39	-0.26	0.39	-0.46	0.11	0.23	0.59	0.42
Other Current Liab	0.62	0.25		0.96	0.74	-0.88	0.7	-0.83	0.91	0.25	-0.84	0.53	0.3	-0.84	0.43	0.62	0.47	0.87	-0.61	0.81	0.48	-0.76	-0.73	0.92	0.3	0.75
Total Current Liabilities	0.75	0.31	0.96		0.85	-0.88	0.84	-0.92	0.98	0.31	-0.91	0.64	0.34	-0.92	0.57	0.78	0.61	0.91	-0.79	0.8	0.64	-0.87	-0.83	0.99	0.43	0.87
Total Stockholder Equity	0.96	0.45	0.74	0.85		-0.88	1.0	-0.98	0.83	0.37	-0.92	0.47	0.68	-0.97	0.52	0.63	0.9	0.88	-0.97	0.66	0.91	-1.0	-0.8	0.81	0.79	1.0
Other Liab	-0.79	-0.57	-0.88	-0.88	-0.88		-0.86	0.9	-0.78	-0.5	0.84	-0.24	-0.7	0.91	-0.46	-0.42	-0.71	-0.83	0.74	-0.62	-0.68	0.89	0.61	-0.79	-0.65	-0.86
Net Tangible Assets	0.96	0.5	0.7	0.84	1.0	-0.86		-0.97	0.81	0.42	-0.9	0.45	0.69	-0.96	0.55	0.63	0.91	0.85	-0.98	0.61	0.91	-1.0	-0.77	0.8	0.81	0.99
Property Plant And Equipment Net	-0.89	-0.37	-0.83	-0.92	-0.98	0.9	-0.97		-0.88	-0.33	0.98	-0.53	-0.57	1.0	-0.58	-0.68	-0.8	-0.95	0.93	-0.73	-0.81	0.99	0.84	-0.89	-0.66	-0.99
Current Deferred Revenue	0.76	0.19	0.91	0.98	0.83	-0.78	0.81	-0.88		0.18	-0.88	0.78	0.23	-0.87	0.51	0.88	0.61	0.89	-0.8	0.84	0.66	-0.84	-0.9	0.99	0.4	0.84
Net Debt	0.31	0.98	0.25	0.31	0.37	-0.5	0.42	-0.33	0.18		-0.16	-0.33	0.59	-0.3	0.67	0.04	0.33	0.06	-0.32	-0.31	0.25	-0.39	0.16	0.25	0.43	0.35
Retained Earnings	-0.81	-0.19	-0.84	-0.91	-0.92	0.84	-0.9	0.98	-0.88	-0.16		-0.6	-0.42	0.98	-0.53	-0.69	-0.69	-0.99	0.88	-0.82	-0.72	0.93	0.88	-0.9	-0.52	-0.94
Accounts Payable	0.46	-0.36	0.53	0.64	0.47	-0.24	0.45	-0.53	0.78	-0.33	-0.6		-0.28	-0.51	0.24	0.93	0.32	0.64	-0.56	0.78	0.44	-0.48	-0.88	0.73	0.06	0.51
Cash	0.72	0.73	0.3	0.34	0.68	-0.7	0.69	-0.57	0.23	0.59	-0.42	-0.28		-0.58	0.16	-0.08	0.8	0.36	-0.58	0.09	0.71	-0.66	-0.17	0.21	0.91	0.63
Non Current Assets Total	-0.89	-0.35	-0.84	-0.92	-0.97	0.91	-0.96	1.0	-0.87	-0.3	0.98	-0.51	-0.58		-0.52	-0.64	-0.8	-0.96	0.92	-0.76	-0.8	0.98	0.84	-0.88	-0.66	-0.98
Non Currrent Assets Other	0.33	0.56	0.43	0.57	0.52	-0.46	0.55	-0.58	0.51	0.67	-0.53	0.24	0.16	-0.52		0.54	0.25	0.44	-0.56	0.07	0.25	-0.55	-0.29	0.61	0.17	0.55
Other Assets	0.6	0.0	0.62	0.78	0.63	-0.42	0.63	-0.68	0.88	0.04	-0.69	0.93	-0.08	-0.64	0.54		0.46	0.68	-0.72	0.67	0.56	-0.65	-0.85	0.86	0.22	0.67
Cash And Short Term Investments	0.98	0.47	0.47	0.61	0.9	-0.71	0.91	-0.8	0.61	0.33	-0.69	0.32	0.8	-0.8	0.25	0.46		0.64	-0.9	0.48	0.99	-0.88	-0.66	0.55	0.96	0.88
Net Receivables	0.77	0.09	0.87	0.91	0.88	-0.83	0.85	-0.95	0.89	0.06	-0.99	0.64	0.36	-0.96	0.44	0.68	0.64		-0.82	0.89	0.67	-0.89	-0.9	0.9	0.46	0.9
Common Stock Total Equity	-0.95	-0.39	-0.61	-0.79	-0.97	0.74	-0.98	0.93	-0.8	-0.32	0.88	-0.56	-0.58	0.92	-0.56	-0.72	-0.9	-0.82		-0.6	-0.92	0.97	0.82	-0.78	-0.78	-0.97
Common Stock Shares Outstanding	0.62	-0.26	0.81	0.8	0.66	-0.62	0.61	-0.73	0.84	-0.31	-0.82	0.78	0.09	-0.76	0.07	0.67	0.48	0.89	-0.6		0.54	-0.66	-0.92	0.8	0.26	0.68
Short Term Investments	0.98	0.39	0.48	0.64	0.91	-0.68	0.91	-0.81	0.66	0.25	-0.72	0.44	0.71	-0.8	0.25	0.56	0.99	0.67	-0.92	0.54		-0.89	-0.73	0.59	0.92	0.89
Non Current Liabilities Total	-0.95	-0.46	-0.76	-0.87	-1.0	0.89	-1.0	0.99	-0.84	-0.39	0.93	-0.48	-0.66	0.98	-0.55	-0.65	-0.88	-0.89	0.97	-0.66	-0.89		0.8	-0.84	-0.77	-1.0
Capital Lease Obligations	-0.78	0.11	-0.73	-0.83	-0.8	0.61	-0.77	0.84	-0.9	0.16	0.88	-0.88	-0.17	0.84	-0.29	-0.85	-0.66	-0.9	0.82	-0.92	-0.73	0.8		-0.86	-0.43	-0.82
Inventory	0.71	0.23	0.92	0.99	0.81	-0.79	0.8	-0.89	0.99	0.25	-0.9	0.73	0.21	-0.88	0.61	0.86	0.55	0.9	-0.78	0.8	0.59	-0.84	-0.86		0.34	0.84
Other Current Assets	0.89	0.59	0.3	0.43	0.79	-0.65	0.81	-0.66	0.4	0.43	-0.52	0.06	0.91	-0.66	0.17	0.22	0.96	0.46	-0.78	0.26	0.92	-0.77	-0.43	0.34		0.76
Other Stockholder Equity	0.95	0.42	0.75	0.87	1.0	-0.86	0.99	-0.99	0.84	0.35	-0.94	0.51	0.63	-0.98	0.55	0.67	0.88	0.9	-0.97	0.68	0.89	-1.0	-0.82	0.84	0.76

Click cells to compare fundamentals

Rxsight Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Rxsight Stock Analysis

When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Rxsight Free Cash Flow Per Share vs Free Cash Flow Yield Analysis

Free Cash Flow Per Share vs Free Cash Flow Yield

Free Cash Flow Per Share vs Free Cash Flow Yield Correlation Analysis

Correlation Coefficient

Free Cash Flow Per Share

Free Cash Flow Yield

Rxsight fundamental ratios Correlations

Rxsight Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Rxsight Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Tangible Assets	+ 1.0	Total Stockholder Equity
Other Stockholder Equity	+ 1.0	Total Stockholder Equity
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Inventory	+ 0.99	Total Current Liabilities
Other Stockholder Equity	+ 0.99	Net Tangible Assets
Non Current Liabilities Total	+ 0.99	Property Plant And Equipment Net

Other Stockholder Equity	- 1.0	Non Current Liabilities Total
Non Current Liabilities Total	- 1.0	Net Tangible Assets
Non Current Liabilities Total	- 1.0	Total Stockholder Equity
Net Receivables	- 0.99	Retained Earnings
Other Stockholder Equity	- 0.99	Property Plant And Equipment Net
Other Stockholder Equity	- 0.98	Non Current Assets Total